CO
COR
HealthcareCencora, Inc.
Medical Distribution
Total Trades
16
Unique Traders
4
Purchases / Sales
4/12
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Jan 29, 2026 |  Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $351.50 | $372.14 | +5.9% | +7.0% | |
Dec 15, 2025 |  Michael T. McCaulR | Stock | Buy | $100,001 - $250,000 | $349.72 | $349.33 | -0.1% | -1.8% | |
Dec 4, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $337.05 | $338.29 | +0.4% | +0.3% | |
Oct 27, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $335.50 | $368.53 | +9.8% | +10.7% | |
Aug 22, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $291.62 | $289.05 | -0.9% | -4.0% | |
Aug 7, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $277.42 | $292.02 | +5.3% | +2.9% | |
Jun 27, 2025 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $298.37 | $289.34 | -3.0% | -6.6% | |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $50,001 - $100,000 | $276.87 | $285.64 | +3.2% | +0.0% | |
Mar 27, 2025 |  Greg LandsmanD | Stock | Sell | $15,001 - $50,000 | $272.02 | $283.86 | +4.4% | +7.3% | |
Feb 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $248.75 | $272.02 | +9.4% | +13.6% | |
Feb 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $243.67 | $265.53 | +9.0% | +16.7% | |
Jan 22, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $245.07 | $240.12 | -2.0% | -0.9% | |
Jan 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $240.20 | $241.31 | +0.5% | -1.6% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $225.25 | $240.20 | +6.6% | +4.4% | |
Dec 13, 2024 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $230.46 | $234.38 | +1.7% | +5.3% | |
Dec 13, 2024 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $230.46 | $234.38 | +1.7% | +5.3% |
Recent News
Cencora (COR) Stock Trades Up, Here Is Why
Yahoo-Invalid Date
Evercore ISI Group Maintains Outperform on Cencora, Lowers Price Target to $420
Benzinga-Invalid Date
Cencora Q1 Earnings Call Highlights
Yahoo-Invalid Date
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
Yahoo-Invalid Date
Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges
Yahoo-Invalid Date